Literature DB >> 20680360

Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.

Benoît Muylkens1, Damien Coupeau, Ginette Dambrine, Sascha Trapp, Denis Rasschaert.   

Abstract

Mdv1-miR-M4 is one of 25 microRNAs (miRNAs) expressed by Marek's disease virus (MDV-1), an oncogenic alphaherpesvirus that induces fatal T-cell lymphoma in chickens. Mdv1-miR-M4 was shown to be the second functional viral ortholog of miR-155, a cellular miRNA that plays a crucial role in several physiological and pathological processes in lymphocyte biology. In this study, we investigated a panel of putative mdv1-miR-M4 targets involved in gene networks affecting both cellular and viral life cycles. Using luciferase reporter assays, we showed that mdv1-miR-M4-5P and miR-155 efficiently targeted a common set of 3' untranslated regions (3'UTR) of six cellular genes (GPM6B, RREB1, c-Myb, MAP3K7IP2, PU.1 and C/EBP). In addition, we also investigated the interactions between mdv1-miR-M4-5P and mdv1-miR-M43P and viral mRNAs encoding UL28 and UL32 in both reporter and western blot assays. Mdv1-miR-M4 specifically inhibited the translation of these two viral proteins, which are involved in the cleavage/packaging of herpesvirus DNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680360     DOI: 10.1007/s00705-010-0777-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

Review 3.  HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis.

Authors:  Irina Haecker; Rolf Renne
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2014       Impact factor: 1.807

4.  Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.

Authors:  Yuguang Zhao; Hongtao Xu; Yongxiu Yao; Lorraine P Smith; Lydia Kgosana; James Green; Lawrence Petherbridge; Susan J Baigent; Venugopal Nair
Journal:  PLoS Pathog       Date:  2011-02-24       Impact factor: 6.823

5.  In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas.

Authors:  Pu Zhao; Xiu-Jie Li; Man Teng; Lu Dang; Zu-Hua Yu; Jia-Qi Chi; Jing-Wei Su; Gai-Ping Zhang; Jun Luo
Journal:  Virus Genes       Date:  2015-02-11       Impact factor: 2.332

6.  Comparative Transcriptome Analysis of Bombyx mori (Lepidoptera) Larval Midgut Response to BmNPV in Susceptible and Near-Isogenic Resistant Strains.

Authors:  Xue-Yang Wang; Hai-Zhong Yu; Lei Geng; Jia-Ping Xu; Dong Yu; Shang-Zhi Zhang; Yan Ma; Dong-Qiong Fei
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

7.  Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Inhibits RNA-Mediated Gene Silencing by Targeting Ago-2.

Authors:  Jing Chen; Xibao Shi; Xiaozhuan Zhang; Li Wang; Jun Luo; Guangxu Xing; Ruiguang Deng; Hong Yang; Jinting Li; Aiping Wang; Gaiping Zhang
Journal:  Viruses       Date:  2015-10-23       Impact factor: 5.048

8.  Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.

Authors:  Isabelle Gennart; Astrid Petit; Laetitia Wiggers; Srđan Pejaković; Nicolas Dauchot; Sylvie Laurent; Damien Coupeau; Benoît Muylkens
Journal:  Microorganisms       Date:  2021-06-21

Review 9.  The miRNA world of polyomaviruses.

Authors:  Ole Lagatie; Luc Tritsmans; Lieven J Stuyver
Journal:  Virol J       Date:  2013-08-28       Impact factor: 4.099

Review 10.  Role of virus-encoded microRNAs in Avian viral diseases.

Authors:  Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2014-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.